Aclaris Therapeutics, Inc. (ACRS)
Largest Insider Buys in Sector
ACRS Stock Price History Chart
ACRS Stock Performance
About Aclaris Therapeutics, Inc.
Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant unmet needs for immuno-inflammatory diseases. The Contract Research segment engages in the provision of laboratory services. The company also develops Zunsemetinib, an MK2 inhibitor for the treatment of …
Insider Activity of Aclaris Therapeutics, Inc.
Over the last 12 months, insiders at Aclaris Therapeutics, Inc. have bought $5.61M and sold $0 worth of Aclaris Therapeutics, Inc. stock.
On average, over the past 5 years, insiders at Aclaris Therapeutics, Inc. have bought $2.94M and sold $8.65M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Leonard Braden Michael (10 percent owner) — $33.55M. Powell Andrew Kenneth William (director) — $17,955.
The last purchase of 206,025 shares for transaction amount of $256,357 was made by Leonard Braden Michael (10 percent owner) on 2024‑08‑05.
List of Insider Buy and Sell Transactions, Aclaris Therapeutics, Inc.
| 2024-08-05 | 10 percent owner | 206,025 0.2901% | $1.24 | $256,357 | -4.84% | |||
| 2024-08-02 | 10 percent owner | 167,544 0.2372% | $1.29 | $216,400 | -7.81% | |||
| 2024-07-31 | 10 percent owner | 100,000 0.1421% | $1.33 | $132,640 | -0.48% | |||
| 2024-07-30 | 10 percent owner | 173,730 0.2425% | $1.30 | $226,370 | +1.30% | |||
| 2024-07-22 | 10 percent owner | 17,716 0.0249% | $1.33 | $23,557 | -11.28% | |||
| 2024-07-19 | 10 percent owner | 6,689 0.0092% | $1.30 | $8,696 | -10.23% | |||
| 2024-07-18 | 10 percent owner | 130,317 0.1816% | $1.30 | $169,555 | -9.16% | |||
| 2024-07-05 | 10 percent owner | 123,017 0.1779% | $1.15 | $141,334 | 0.00% | |||
| 2024-07-03 | 10 percent owner | 143,288 0.209% | $1.16 | $166,071 | 0.00% | |||
| 2024-07-02 | 10 percent owner | 86,092 0.1239% | $1.14 | $98,489 | 0.00% | |||
| 2024-07-01 | 10 percent owner | 107,434 0.1538% | $1.14 | $122,185 | 0.00% | |||
| 2024-06-28 | 10 percent owner | 1.2M 1.6972% | $1.12 | $1.35M | 0.00% | |||
| 2024-06-27 | 10 percent owner | 235,000 0.3415% | $1.15 | $271,331 | 0.00% | |||
| 2024-06-18 | 10 percent owner | 50,000 0.0708% | $1.13 | $56,505 | +5.31% | |||
| 2024-06-17 | 10 percent owner | 150,000 0.2124% | $1.13 | $169,500 | +5.31% | |||
| 2024-06-14 | 10 percent owner | 345,000 0.5039% | $1.17 | $402,201 | +0.85% | |||
| 2024-06-13 | 10 percent owner | 528,621 0.7614% | $1.15 | $607,757 | -0.42% | |||
| 2024-06-12 | 10 percent owner | 82,579 0.1179% | $1.14 | $94,140 | +3.48% | |||
| 2024-06-11 | 10 percent owner | 1M 1.3531% | $1.08 | $1.08M | +5.80% | |||
| 2024-03-04 | director | 6,000 0.0083% | $1.25 | $7,500 | -4.80% |
Insider Historical Profitability
| Leonard Braden Michael | 10 percent owner | 14250000 19.9735% | $2.25 | 19 | 0 | |
| Powell Andrew Kenneth William | director | 28863 0.0405% | $2.25 | 3 | 0 | <0.0001% |
| CHA ALBERT | director | 4191397 5.8749% | $2.25 | 2 | 0 | +71.55% |
| FMR LLC | 10 percent owner | 2571354 3.6041% | $2.25 | 1 | 1 | +61.56% |
| Sofinnova Venture Partners VIII, L.P. | 10 percent owner | 2289480 3.209% | $2.25 | 1 | 0 | +61.56% |
Institutional Investor Ownership
| Bml Capital Management Llc | $11.65M | 13.19 | 9.4M | +1,338.65% | +$10.84M | 8.94 | |
| BlackRock | $6.45M | 7.3 | 5.2M | -11.92% | -$872,618.69 | <0.0001 | |
| The Vanguard Group | $6.11M | 6.92 | 4.93M | +4.39% | +$257,198.32 | <0.0001 | |
| D. E. Shaw & Co. | $4.07M | 4.61 | 3.28M | +69.31% | +$1.67M | <0.01 | |
| Millennium Management LLC | $4.06M | 4.59 | 3.27M | -5.92% | -$255,277.55 | <0.01 |